NCT07050875Completed
Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting
Source: ClinicalTrials.gov · Last updated 27 Jan 2026
Brief summary (registry, in English)
The primary objective of the study is to validate the safety and clinical performance of the ABLE Exoskeleton device in people with acquired brain injury during a 10-session gait training program in a clinical setting. The secondary objective of the study focuses on obtaining preliminary data on the potential clinical and psychosocial benefits of the product.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 14 (actual)
- First submitted
- 16 Jun 2025
- Start date
- 30 Jun 2025
- Primary completion date
- 17 Dec 2025
- Lead sponsor
- ABLE Human Motion S.L.
- Diseases
- Stroke
- NCT number
- NCT07050875
What you commit to
- Study type: Interventional
- Participants enrolled: 14
- From 30 Jun 2025 to the primary completion date, 17 Dec 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unresolved fractures in the pelvis or extremities, or history of fragility fractures in the lower extremities in the last 2 years
- Unstable cardiovascular system (CVS), hemodynamic instability, untreated hypertension (SBP\>140, DBP\>90 mmHg), unresolved deep venous thrombosis (DVT), uncontrolled autonomic dysreflexia
- Serious comorbidities, including any condition that a physician deems inappropriate for use of the ABLE Exoskeleton or to complete participation in the study
- Grade I or higher on EPUAP (European Pressure Ulcer Advisory Panel, 2019) on areas that will be in contact with the exoskeleton
- Cognitive impairment that results in the inability to follow simple instructions, particularly psychological or cognitive problems that do not allow a participant to follow study procedures
Other
- Significant osteoporosis that may increase the risk of fracture
- Spinal instability (or spinal orthoses, unless authorized by a physician)
- Severe spasticity: Level 4 on the Modified Ashworth Scale
- Orthostatic hypotension. Inability to tolerate a minimum of 10 minutes standing
- Uncontrolled autonomic dysreflexia
- Medical instability
- Skin integrity problems on the contact surfaces of the device or that would prevent sitting
- Colostomy
- Anthropometric measurements outside the values compatible with ABLE Exoskeleton. In particular, height not between 1.5-1.9 m, or weight over 100 kg
- Anatomical constraints (such as leg length differences, users unable to position themselves inside the device) that are incompatible with the device
- Restrictions in range of motion that prevent normal gait from being achieved or preventing the completion of a normal transition from sitting to standing or standing to sitting
- Heterotopic ossification
- Known pregnancy or breastfeeding
- Requires assisted ventilation.
- Scoliosis \>40-50º Cobb angle.
Who the study is looking for
- 18 to 80 years old
- Diagnosed with acquired brain injury (ABI)
- Currently undergoing outpatient physical therapy treatment in one of the investigation sites
- Ability to give informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cefine Neurología (CEFINE) Coordinator of this site? Confirm its status | Culleredo | Spain | Unknown status |
| Fundación Step by Step Coordinator of this site? Confirm its status | L'Hospitalet de Llobregat | Spain | Unknown status |
| Centro Europeo de Neurociencias (CEN) Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.